ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy.

June 09, 2021 By:
  • Bousquet J
  • Pfaar O
  • Agache I
  • Bedbrook A
  • Akdis CA
  • Canonica GW
  • Chivato T
  • Al-Ahmad M
  • Abdul Latiff AH
  • Ansotegui IJ
  • Bachert C
  • Baharuddin A
  • Bergmann KC
  • Bindslev-Jensen C
  • Bjermer L
  • Bonini M
  • Bosnic-Anticevich S
  • Bosse I
  • Brough HA
  • Brussino L
  • Calderon MA
  • Caraballo L
  • Cardona V
  • Carreiro-Martins P
  • Casale T
  • Cecchi L
  • Cepeda Sarabia AM
  • Chkhartishvili E
  • Chu DK
  • Cirule I
  • Cruz AA
  • Czarlewski W
  • Del Giacco S
  • Demoly P
  • Devillier P
  • Dokic D
  • Durham SL
  • Ebisawa M
  • El-Gamal Y
  • Emuzyte R
  • Gamkrelidze A
  • Fauquert JL
  • Fiocchi A
  • Fokkens WJ
  • Fonseca JA
  • Fontaine JF
  • Gawlik R
  • Gelincik A
  • Gemicioglu B
  • Gereda JE
  • Gerth van Wijk R
  • Gomez RM
  • Gotua M
  • Grisle I
  • Guzman MA
  • Haahtela T
  • Halken S
  • Heffler E
  • Hoffmann-Sommergruber K
  • Hossny E
  • Hrubisko M
  • Irani C
  • Ivancevich JC
  • Ispayeva Z
  • Julge K
  • Kaidashev I
  • Kalayci O
  • Khaitov M
  • Klimek L
  • Knol E
  • Kowalski ML
  • Kraxner H
  • Kull I
  • Kuna P
  • Kvedariene V
  • Kritikos V
  • Lauerma A
  • Lau S
  • Laune D
  • Levin M
  • Larenas-Linnemann DE
  • Lodrup Carlsen KC
  • Lombardi C
  • Lourenco OM
  • Mahboub B
  • Malling HJ
  • Manning P
  • Marshall GD
  • Melen E
  • Meltzer EO
  • Miculinic N
  • Milenkovic B
  • Moin M
  • Montefort S
  • Morais-Almeida M
  • Mortz CG
  • Mosges R
  • Mullol J
  • Namazova Baranova L
  • Neffen H
  • Nekam K
  • Niedoszytko M
  • Odemyr M
  • O'Hehir RE
  • Ollert M
  • O'Mahony L
  • Ohta K
  • Okamoto Y
  • Okubo K
  • Pajno GB
  • Palomares O
  • Palkonen S
  • Panzner P
  • N GP
  • Park HS
  • Passalacqua G
  • Patella V
  • Pawankar R
  • Pham-Thi N
  • Plavec D
  • Popov TA
  • Recto M
  • Regateiro FS
  • Riggioni C
  • Roberts G
  • Rodriguez-Gonzales M
  • Rosario N
  • Rottem M
  • Rouadi PW
  • Ryan D
  • Samolinski B
  • Sanchez-Borges M
  • Serpa FS
  • Sastre J
  • Scadding GK
  • Shamji MH
  • Schmid-Grendelmeier P
  • Schunemann HJ
  • Sheikh A
  • Scichilone N
  • Sisul JC
  • Sofiev M
  • Sole D
  • Sooronbaev T
  • Soto-Martinez M
  • Soto-Quiros M
  • Sova M
  • Schwarze J
  • Skypala I
  • Suppli-Ulrik C
  • Taborda-Barata L
  • Todo-Bom A
  • Torres MJ
  • Valentin-Rostan M
  • Tomazic PV
  • Valero A
  • Toppila-Salmi S
  • Tsiligianni I
  • Untersmayr E
  • Urrutia-Pereira M
  • Valiulis A
  • Valovirta E
  • Vandenplas O
  • Ventura MT
  • Vichyanond P
  • Wagenmann M
  • Wallace D
  • Walusiak-Skorupa J
  • Wang Y
  • Waserman S
  • Wong GW
  • Yorgancioglu A
  • Yusuf OM
  • Zernotti M
  • Zhang L
  • Zidarn M
  • Zuberbier T
  • Jutel M.

Allergen immunotherapy (AIT), the gradually increasing repeated administration of high doses of allergens to allergic patients, offers the potential for immune tolerance against reactions to the natural exposures to specific allergens. AIT may lead to the long-lasting remission of allergic symptoms and is the only disease-modifying intervention in IgE-mediated allergic respiratory diseases.
This Pocket Guide was developed by an ARIA and EAACI joint study group from a background paper of the ARIA-MASK study group and from the EAACI guidelines on allergen immunotherapy.

2021 Jun. Clin Transl Allergy.11(4):e12014.
Other information